Overview Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy Status: Unknown status Trial end date: 2020-04-01 Target enrollment: Participant gender: Summary Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy Phase: Phase 3 Details Lead Sponsor: Tanta UniversityTreatments: DexmedetomidineHypnotics and SedativesPropofol